Dan Littman

Dan Littman

Director/Board Member at PFIZER INC.

Net worth: - $ as of 2026-05-30

73 year
Health Technology
Consumer Services
Commercial Services

Profile

Dan R.
Littman
is the founder of Vedanta Biosciences, Inc., founded in 2010; Orca Pharmaceuticals Ltd., founded in 2012; and Immunai, Inc., founded in 2018.
Dr. Littman currently serves as an Independent Director at Pfizer Inc. since 2018, is a member of the Scientific Advisory Board at ChemoCentryx, Inc., a member of the National Academy of Sciences, a member of the National Academy of Medicine (United States), a Venture Partner at Catalio Capital Management LP, and a Professor at NYU Langone Health since 1995.
Dr. Littman was a Professor at The University of California, San Francisco from 1985 to 1995.
Dr. Littman completed undergraduate education at Princeton University and earned a doctorate from Washington University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-22 0 ( -.--% ) - $ 2026-05-30

Dan Littman active positions

CompaniesPositionStart
PFIZER INC. Director/Board Member 2018-03-04
CHEMOCENTRYX, INC. Consultant / Advisor -
Founder 2009-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal 1994-12-31
Founder 2018-11-30
Private Equity Investor -

Former positions of Dan Littman

CompaniesPositionEnd
Corporate Officer/Principal 1994-12-31
░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ -
See the detail of Dan Littman's experience

Training of Dan Littman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

94

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Services

Consumer Services

Technology Services

Finance

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!